List of Excipients in API MIDAZOLAM HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing MIDAZOLAM HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Meridian Medical Technologies LLC | SEIZALAM | midazolam hydrochloride | 11704-650 | BENZYL ALCOHOL | |
| Meridian Medical Technologies LLC | SEIZALAM | midazolam hydrochloride | 11704-650 | EDETATE DISODIUM | |
| Meridian Medical Technologies LLC | SEIZALAM | midazolam hydrochloride | 11704-650 | HYDROCHLORIC ACID | |
| Meridian Medical Technologies LLC | SEIZALAM | midazolam hydrochloride | 11704-650 | SODIUM CHLORIDE | |
| Meridian Medical Technologies LLC | SEIZALAM | midazolam hydrochloride | 11704-650 | SODIUM HYDROXIDE | |
| Exela Pharma Sciences LLC | MIDAZOLAM HYDROCHLORIDE | midazolam hydrochloride | 51754-2130 | HYDROCHLORIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing MIDAZOLAM HYDROCHLORIDE
Detailed excipient profiles for MIDAZOLAM HYDROCHLORIDE
Excipient focus: ANHYDROUS CITRIC ACID
MIDAZOLAM HYDROCHLORIDE drug variants containing ANHYDROUS CITRIC ACID
MIDAZOLAM HYDROCHLORIDE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BENZYL ALCOHOL
MIDAZOLAM HYDROCHLORIDE drug variants containing BENZYL ALCOHOL
MIDAZOLAM HYDROCHLORIDE drug variants not containing BENZYL ALCOHOL
Excipient focus: CHERRY
MIDAZOLAM HYDROCHLORIDE drug variants containing CHERRY
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | midazolam hydrochloride | 17856-0205 |
| Ranbaxy Pharmaceuticlas Inc | midazolam hydrochloride | 63304-205 |
| >Company | >Ingredient | >NDC |
MIDAZOLAM HYDROCHLORIDE drug variants not containing CHERRY
Excipient focus: CITRIC ACID MONOHYDRATE
MIDAZOLAM HYDROCHLORIDE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | midazolam hydrochloride | 17856-0205 |
| Ranbaxy Pharmaceuticlas Inc | midazolam hydrochloride | 63304-205 |
| >Company | >Ingredient | >NDC |
MIDAZOLAM HYDROCHLORIDE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: D&C RED NO. 33
MIDAZOLAM HYDROCHLORIDE drug variants containing D&C RED NO. 33
MIDAZOLAM HYDROCHLORIDE drug variants not containing D&C RED NO. 33
Excipient focus: EDETATE DISODIUM
MIDAZOLAM HYDROCHLORIDE drug variants containing EDETATE DISODIUM
MIDAZOLAM HYDROCHLORIDE drug variants not containing EDETATE DISODIUM
Excipient focus: GLYCERIN
MIDAZOLAM HYDROCHLORIDE drug variants containing GLYCERIN
MIDAZOLAM HYDROCHLORIDE drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
MIDAZOLAM HYDROCHLORIDE drug variants containing HYDROCHLORIC ACID
MIDAZOLAM HYDROCHLORIDE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | midazolam hydrochloride | 17856-0205 |
| Ranbaxy Pharmaceuticlas Inc | midazolam hydrochloride | 63304-205 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
MIDAZOLAM HYDROCHLORIDE drug variants containing SACCHARIN SODIUM
MIDAZOLAM HYDROCHLORIDE drug variants not containing SACCHARIN SODIUM
Excipient focus: SACCHARIN SODIUM DIHYDRATE
MIDAZOLAM HYDROCHLORIDE drug variants containing SACCHARIN SODIUM DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | midazolam hydrochloride | 17856-0205 |
| >Company | >Ingredient | >NDC |
MIDAZOLAM HYDROCHLORIDE drug variants not containing SACCHARIN SODIUM DIHYDRATE
Excipient focus: SODIUM BENZOATE
MIDAZOLAM HYDROCHLORIDE drug variants containing SODIUM BENZOATE
MIDAZOLAM HYDROCHLORIDE drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM CHLORIDE
MIDAZOLAM HYDROCHLORIDE drug variants containing SODIUM CHLORIDE
MIDAZOLAM HYDROCHLORIDE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
MIDAZOLAM HYDROCHLORIDE drug variants containing SODIUM CITRATE
MIDAZOLAM HYDROCHLORIDE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
MIDAZOLAM HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
MIDAZOLAM HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SORBITOL
MIDAZOLAM HYDROCHLORIDE drug variants containing SORBITOL
MIDAZOLAM HYDROCHLORIDE drug variants not containing SORBITOL
Excipient focus: WATER
MIDAZOLAM HYDROCHLORIDE drug variants containing WATER
MIDAZOLAM HYDROCHLORIDE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
